Analysts Boost Price Targets on Corcept (CORT) Following FDA Approval of Korlym
Go back to Analysts Boost Price Targets on Corcept (CORT) Following FDA Approval of Korlym| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 89.57 -0.9 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.47 | 52 Week High | $10.00 | |||
| Open | $90.30 | 52 Week Low | $3.22 | |||
| Day High | $90.45 | P/E | N/A | |||
| Day Low | $86.14 | EPS | $-0.46 | |||
| Volume | 1,019,930 | |||||
